<DOC>
	<DOCNO>NCT00202436</DOCNO>
	<brief_summary>In project plan evaluate effectiveness erythrocytapheresis phlebotomy , regard impact reduction iron overload well reduction patient `` burden '' . Aspects cost effectiveness include final analysis . Results study would allow decision-making base Evidence Based Medicine `` best '' therapeutic option available newly-diagnosed well exist primary hemochromatosis patient .</brief_summary>
	<brief_title>Haemochromatosis : Phlebotomy Versus Erythrocytapheresis Therapy</brief_title>
	<detailed_description>In project plan evaluate effectiveness erythrocytapheresis phlebotomy , regard impact reduction iron overload well reduction patient `` burden '' . Aspects cost effectiveness include final analysis . The result study would allow decision-making base Evidence Based Medicine `` best '' therapeutic option available newly-diagnosed well exist primary hemochromatosis patient .</detailed_description>
	<mesh_term>Hemochromatosis</mesh_term>
	<criteria>Hereditary haemochromatosis patient Malignancies , severe arrhythmia , congestive heart failure and/or recent angina , severe liver disease , epileptic seizure precede last 3 month plan treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>